Tag Archives: miracle

Ocata publishes Phase 2 trial protocol!!

Here it is!! On clinicaltrials.gov!! YES and YAY. We are getting closer and closer to a cure for the most common cause of blindness in the developed world. There’s only one possible response to this… make a pumpkin pie! 🙂 (Oh, okay, I was already going to do that anyway…) But I’ll let you know how it turned out. For a truly excellent article explaining what this means, I’ll send you to the one and only Dr. Hartman’s (aka Deadally’s) analysis on Seeking Alpha:
Ocata Therapeutics Is An Official Phase 2 Biotech: AMD Efficacy Study Design Details

And here’s a comment I just left on the article:

Thanks so much for this excellent article, Dr. Hartman! 🙂 So many people could be helped this way. And as I know all too well… NOT everyone who has some form of MD is ninety years old. I’m certainly not, but it does get worse than that. Every time I’ve been at Casey Eye Institute, I’ve seen small children with Stargardt’s. It’s one of the saddest sights you could ever imagine. I know I’ll never forget the time I saw a baby with bandages over its face being wheeled down the hall in a huge cot enclosed by bars. What Ocata is doing will ultimately provide the opportunity to save people of all ages from blindness.

Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE Studies

Here’s a cogent, intelligent, and rational comment to the news below:
3458qu9fqu4589q3u-!!!!! OMG I DON’T EVEN. O.o.
This moment has been brought to you by the Department of Medical Miracles to Come. 🙂
THIS IS WHAT WE’VE BEEN WAITING FOR!!! It’s the OFFICIAL announcement! Ocata can now start the second trial! They have pivotal trial status from the European Medicines Agency! This means that they can start marketing the drug after the next trial is over! It would be the FIRST stem cell based drug approved since 1956! Yes, I really DO think that we need all of these exclamation points!!!

Capslock? What capslock? 😉

Ahem. Anyway, check it out. 🙂
Ocata’s Press Release on the Completion of Phase I/II of SMD Trials